EP4188331A4 - Lentille de contact chargée à surface limite destinée à une administration - Google Patents
Lentille de contact chargée à surface limite destinée à une administrationInfo
- Publication number
- EP4188331A4 EP4188331A4 EP21904586.1A EP21904586A EP4188331A4 EP 4188331 A4 EP4188331 A4 EP 4188331A4 EP 21904586 A EP21904586 A EP 21904586A EP 4188331 A4 EP4188331 A4 EP 4188331A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- distribution
- contact lens
- charged limit
- charged
- limit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Eyeglasses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063123237P | 2020-12-09 | 2020-12-09 | |
| PCT/US2021/072779 WO2022126100A1 (fr) | 2020-12-09 | 2021-12-07 | Lentille de contact chargée à surface limite destinée à une administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4188331A1 EP4188331A1 (fr) | 2023-06-07 |
| EP4188331A4 true EP4188331A4 (fr) | 2025-10-29 |
Family
ID=81974028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21904586.1A Pending EP4188331A4 (fr) | 2020-12-09 | 2021-12-07 | Lentille de contact chargée à surface limite destinée à une administration |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11504323B2 (fr) |
| EP (1) | EP4188331A4 (fr) |
| JP (1) | JP2023533421A (fr) |
| CN (1) | CN115379826B (fr) |
| WO (1) | WO2022126100A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023523398A (ja) * | 2020-04-15 | 2023-06-05 | リンセラ コーポレイション | 多孔性ナノコンポジット医療用インプラント装置 |
| WO2024015959A1 (fr) | 2022-07-15 | 2024-01-18 | Praful Doshi | Lentilles de contact avec médicaments et leurs procédés de fabrication et d'utilisation faisant intervenir des stabilisants de composants labiles tels que des médicaments |
| GB2629236B (en) * | 2024-01-24 | 2025-07-16 | Coopervision Int Ltd | Contact Lens Formulation and Contact Lens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2902007B1 (fr) * | 2006-06-09 | 2012-01-13 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques |
| US9248928B2 (en) * | 2012-12-21 | 2016-02-02 | Coopervision International Holding Company, Lp | Methods of manufacturing contact lenses for delivery of beneficial agents |
| JP2019530556A (ja) * | 2016-09-30 | 2019-10-24 | リンセラ コーポレイション | 二重領域眼球用デバイスによる高精度薬物送達 |
| JP2022540583A (ja) * | 2019-07-17 | 2022-09-16 | テオン セラピューティクス,インク. | アデノシンa2a受容体アンタゴニスト及びその使用 |
| JP2023523398A (ja) | 2020-04-15 | 2023-06-05 | リンセラ コーポレイション | 多孔性ナノコンポジット医療用インプラント装置 |
-
2021
- 2021-12-07 JP JP2022569187A patent/JP2023533421A/ja active Pending
- 2021-12-07 CN CN202180026742.XA patent/CN115379826B/zh active Active
- 2021-12-07 WO PCT/US2021/072779 patent/WO2022126100A1/fr not_active Ceased
- 2021-12-07 EP EP21904586.1A patent/EP4188331A4/fr active Pending
-
2022
- 2022-03-15 US US17/654,963 patent/US11504323B2/en active Active
Non-Patent Citations (5)
| Title |
|---|
| BENGANI LOKENDRAKUMAR C. ET AL: "Extended delivery of an anionic drug by contact lens loaded with a cationic surfactant", BIOMATERIALS, vol. 34, no. 11, 1 April 2013 (2013-04-01), AMSTERDAM, NL, pages 2814 - 2821, XP055813811, ISSN: 0142-9612, DOI: 10.1016/j.biomaterials.2012.12.027 * |
| CESAR TORRES-LUNA ET AL: "Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants", CONTACT LENS AND ANTERIOR EYE, vol. 42, no. 5, 1 October 2019 (2019-10-01), GB, pages 546 - 552, XP055686052, ISSN: 1367-0484, DOI: 10.1016/j.clae.2019.04.011 * |
| See also references of WO2022126100A1 * |
| TORRES-LUNA CESAR ET AL: "Effect of Carbon Chain Length, Ionic Strength, and pH on the In Vitro Release Kinetics of Cationic Drugs from Fatty-Acid-Loaded Contact Lenses", PHARMACEUTICS, vol. 13, no. 7, 10 July 2021 (2021-07-10), Switzerland, pages 1060, XP093313745, ISSN: 1999-4923, DOI: 10.3390/pharmaceutics13071060 * |
| TORRES-LUNA CESAR ET AL: "Extended delivery of cationic drugs from contact lenses loaded with unsaturated fatty acids", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 155, 1 October 2020 (2020-10-01), NL, pages 1 - 11, XP055884167, ISSN: 0939-6411, Retrieved from the Internet <URL:https://www.sciencedirect.com/science/article/pii/S0939641120302368/pdfft?md5=c203f09e748313eef25cdf077d3ba745&pid=1-s2.0-S0939641120302368-main.pdf> DOI: 10.1016/j.ejpb.2020.07.033 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US11504323B2 (en) | 2022-11-22 |
| JP2023533421A (ja) | 2023-08-03 |
| CN115379826B (zh) | 2023-07-21 |
| CN115379826A (zh) | 2022-11-22 |
| US20220192975A1 (en) | 2022-06-23 |
| WO2022126100A1 (fr) | 2022-06-16 |
| EP4188331A1 (fr) | 2023-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4188331A4 (fr) | Lentille de contact chargée à surface limite destinée à une administration | |
| EP3610192C0 (fr) | Lentille hybride pour distribution de rétroéclairage commandée | |
| HUE062735T2 (hu) | Szilikon hidrogél kontaktlencsék nem egységes morfológiával | |
| EP3942358A4 (fr) | Lentille de contact | |
| EP2926967C0 (fr) | Lentille de contact en hydrogel de silicone présentant une surface hydrophile | |
| EP3780136A4 (fr) | Cellule | |
| EP3052983C0 (fr) | Lentille ophtalmique en vue de la correction de l'astigmatisme | |
| GB2608495B (en) | WS12-releasing contact lens | |
| HUE061825T2 (hu) | Eljárás szilikonhidrogél kontaktlencsék elõállítására | |
| EP3806494C0 (fr) | Dispositif auditif comprenant un capteur optique | |
| SG11202009913UA (en) | Method for making silicone hydrogel contact lenses | |
| GB2563182B (en) | Silicone elastomer-silicone hydrogel hybrid contact lenses | |
| SG11202007012TA (en) | Method for making silicone hydrogel contact lenses | |
| PL3792549T3 (pl) | Urządzenie optyczne do modyfikacji rozkładu światła | |
| EP3846924A4 (fr) | Procédés de culture cellulaire continue | |
| HUE062555T2 (hu) | Eljárás bevonatos szilikonhidrogél-kontaktlencsék elõállítására | |
| EP3482236C0 (fr) | Lentilles de contact souples avec une rigidité centrale élevée pour corriger l'astigmatisme | |
| HUE047786T2 (hu) | Eljárás csökkentett párolgási sebességû szilikon hidrogél kontaktlencsék gyártására | |
| EP3954003A4 (fr) | Épissure de contact | |
| EP4006625A4 (fr) | Lentille de contact et moule pour la fabrication de celle-ci | |
| EP3953642C0 (fr) | Dispositif optique pour modifier la diffusion lumineuse | |
| EP3973275C0 (fr) | Système libs à mise au point automatique | |
| PL3797333T3 (pl) | Miękkie soczewki kontaktowe | |
| EP3566095A4 (fr) | Lentille de contact prismatique | |
| EP4229452A4 (fr) | Lentilles de contact de correction d'astigmatisme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20230228 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20250930 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/00 20060101AFI20250924BHEP Ipc: A61L 27/54 20060101ALI20250924BHEP Ipc: A61F 9/00 20060101ALI20250924BHEP Ipc: G02C 7/04 20060101ALI20250924BHEP |